Werewolf Therapeutics (HOWL.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Nov18

US Bank Securities Analyst Reiterates Buy Rating on Werewolf Therapeutics

11:47

Nov7

Werewolf Therapeutics presented new preclinical data at the SITC annual meeting

14:01

Nov5

Werewolf Therapeutics released FY2025 Q3 earnings on November 4 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.3599 (forecast USD -0.39)

04:00

Werewolf Therapeutics released FY2025 9 Months Earnings on November 4 (EST), actual revenue USD 0, actual EPS USD -1.1635

04:00

Nov4

Werewolf Therapeutics Inc. Reports Q3 Earnings and Updates Pipeline Progress

12:01

Oct29

MPM BioVentures 2014, L.P. Sells Shares of Werewolf Therapeutics Inc.

23:22

Schedules & Filings

Schedules

Filings

Nov4

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -16.37 M, EPS -0.3599

Aug14

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -17.98 M, EPS -0.3999

May8

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -18.09 M, EPS -0.4035

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change